Gilead Sciences Investor
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Technology:
Others
Industry:
Longevity Industry 2022
Headquarters:
Foster City, California, United States
Founded Date:
1987-06-22
Employees Number:
10001+
Funding Status:
IPO
Number Of Exits:
11
Acquisitions Number:
Made Acquisitions
Investors Number:
1
Estimated Revenue:
$1B to $10B
Last Funding Date:
1988-01-01
Last Funding Type:
Seed
Register and Claim Ownership